Adjuvanted recombinant hemagglutinin H7 vaccine to highly pathogenic influenza A(H7N9) elicits high and sustained antibody responses in healthy adults

An unprecedented number of human infections with avian influenza A(H7N9) in the fifth epidemic wave during the winter of 2016–2017 in China and their antigenic divergence from the viruses that emerged in 2013 prompted development of updated vaccines for pandemic preparedness. We report on the findin...

Descripción completa

Detalles Bibliográficos
Autores principales: Oshansky, Christine M., King, James, Lu, Di, Zhou, James, Pavetto, Corrina, Horwith, Gary, Biscardi, Karen, Nguyen, Bai, Treanor, John J., Chen, Li-Mei, Jepson, Brett, Bright, Rick A., Johnson, Robert A., Cioce, Vittoria, Donis, Ruben O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7979905/
https://www.ncbi.nlm.nih.gov/pubmed/33741987
http://dx.doi.org/10.1038/s41541-021-00287-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7979905/
https://www.ncbi.nlm.nih.gov/pubmed/33741987
http://dx.doi.org/10.1038/s41541-021-00287-7

Ejemplares similares